|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0411 - 0.0705|
|52 Week Range||0.0200 - 0.1300|
|Beta (5Y Monthly)||0.28|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 28, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
LAS VEGAS, NV / ACCESSWIRE / January 25, 2021 / GB Sciences, Inc. (OTCQB:GBLX), through GBS Global Biopharma, Inc.
LAS VEGAS, NV / ACCESSWIRE / January 12, 2021 / GB Sciences, Inc. (OTCQB:GBLX) completed the sale of its remaining interest in GB Sciences Louisiana LLC ("GBSLA") on December 16, 2020.
LAS VEGAS / ACCESSWIRE / December 8, 2020 / GB Sciences, Inc.